EichorEICHOR
Location: Lampasas Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Lampasas

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Phase 3 · GMG Clinical Research, LLC dba Radiance Clinical Research · Kallyope Inc. · NCT07674654Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Ch
Phase 3 · FMC Science /ID# 231915 · AbbVie · NCT05125302Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Con
Phase 3 · Radiance Clinical Research - Lampasas - West Avenue East- Si · Sanofi · NCT07190209A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabe
Phase 2 · Radiance Clinical Research · Novo Nordisk A/S · NCT07668388Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Phase 3 · GMG Clinical Research (DBA Radiance Clinical Research) - Lam · Eli Lilly and Company · NCT07157774Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and T
Phase 3 · GSK Investigational Site · GlaxoSmithKline · NCT06961214Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Phase 2 · Radiance Clinical Research · Sparrow Pharmaceuticals · NCT07296484A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obe
Phase 3 · Radiance Clinical Research · Novo Nordisk A/S · NCT07564414A Study to Assess the Safety, Tolerability and Efficacy of ION775
Phase 2 · Ionis Investigative Site · Ionis Pharmaceuticals, Inc. · NCT07604974A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Phase 3 · GMG Clinical Research, LLC dba Radiance Clinical Research · Kallyope Inc. · NCT07645924
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.